All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F16%3A10327302" target="_blank" >RIV/00064165:_____/16:10327302 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/16:00091332 RIV/00216208:11110/16:10327302 RIV/65269705:_____/16:00065609

  • Result on the web

    <a href="http://dx.doi.org/10.1186/s12969-016-0099-z" target="_blank" >http://dx.doi.org/10.1186/s12969-016-0099-z</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s12969-016-0099-z" target="_blank" >10.1186/s12969-016-0099-z</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration

  • Original language description

    Background: There is a lack of published evidence on the importance of methotrexate (MTX) dose and route of administration on both its efficacy and adverse events in children with Juvenile Idiopathic Arthritis (JIA). We aimed to document our clinical practice based on the treat-to-target approach in order to support the concept that better therapeutic effect achieved with an optimal dose of parenteral MTX is associated with clinically acceptable adverse effects comparable to those reported for oral treatment. Methods: Study inclusion criteria were indication of new MTX therapy for active arthritis in confirmed JIA patients younger than 18 years. Eligible patients were evaluated prospectively every 3 months for 1 year using standardized instruments for treatment response (American College of Rheumatology Pediatric (ACRPedi) response, Juvenile Arthritis Disease Activity Score (JADAS) 71, Clinically Inactive Disease (CID)) and adverse events (laboratory monitoring, Methotrexate Intolerance Severity Score (MISS)). MTX responders had to achieve at least ACRPedi 70 response. MTX intolerance was defined by MISS >=6.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FG - Paediatrics

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NT14149" target="_blank" >NT14149: Quality of life in children with juvenile idiopathic arthritis: Importance of allied health professions in the complex treatment programme</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Pediatric Rheumatology

  • ISSN

    1546-0096

  • e-ISSN

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    June

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    11

  • Pages from-to

  • UT code for WoS article

    000377783400001

  • EID of the result in the Scopus database

    2-s2.0-84974828478